AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Sternberg, CN
Citation: Cn. Sternberg, Systemic treatment and new developments in advanced prostate cancer, EUR J CANC, 37, 2001, pp. S147-S157

Authors: Sternberg, CN Parmar, MKB
Citation: Cn. Sternberg et Mkb. Parmar, Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer, J CL ONCOL, 19(18), 2001, pp. 21S-27S

Authors: Sternberg, CN de Mulder, PHM Schornagel, JH Theodore, C Fossa, SD van Oosterom, AT Witjes, F Spina, M van Groeningen, CJ de Balincourt, C Collette, L
Citation: Cn. Sternberg et al., Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy amd recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for research and treatment of cancerprotocol no. 30924, J CL ONCOL, 19(10), 2001, pp. 2638-2646

Authors: Sternberg, CN Calabro, F
Citation: Cn. Sternberg et F. Calabro, Neo-adjuvant chemotherapy in invasive bladder cancer, WORLD J URO, 19(2), 2001, pp. 94-98

Authors: Williams, SG Gandour-Edwards, R Deitch, AD Toscano, S Fan, JJ Sternberg, CN Pansadoro, V Calabro, F Rossetti, A White, RWD
Citation: Sg. Williams et al., Differences in gene expression in muscle-invasive bladder cancer: A comparison of Italian and American patients, EUR UROL, 39(4), 2001, pp. 430-437

Authors: Sternberg, CN Calabro, F
Citation: Cn. Sternberg et F. Calabro, Chemotherapy and management of bladder tumours, BJU INT, 85(5), 2000, pp. 599-610

Authors: De Mulder, PHM Theodore, C Sella, A Koriakine, O Sternberg, CN Collette, L de Balincourt, C
Citation: Phm. De Mulder et al., Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tract, ANN ONCOL, 11(11), 2000, pp. 1391-1394

Authors: Ramacciato, G Aurello, P D'Angelo, F Cicchini, C Sternberg, CN
Citation: G. Ramacciato et al., Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?, HEP-GASTRO, 47(35), 2000, pp. 1470-1474

Authors: Sternberg, CN
Citation: Cn. Sternberg, Gemcitabine in bladder cancer, SEMIN ONCOL, 27(1), 2000, pp. 31-39

Authors: Sternberg, CN
Citation: Cn. Sternberg, Hormonal therapy and radiation therapy in the treatment of locally advanced prostate cancer, MOL UROL, 3(3), 1999, pp. 227-229

Authors: Pansadoro, V Sternberg, CN
Citation: V. Pansadoro et Cn. Sternberg, Neoadjuvant hormonal therapy and radical prostatectomy for locally advanced prostate cancer, MOL UROL, 3(3), 1999, pp. 271-274

Authors: Sternberg, CN
Citation: Cn. Sternberg, A critical review of the management of bladder cancer, CR R ONC H, 31(3), 1999, pp. 193-207

Authors: Sternberg, CN Pansadoro, V Calabro, F Marini, L van Rijn, A De Carli, P Giannarelli, D Platania, A Rossetti, A
Citation: Cn. Sternberg et al., Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder, ANN ONCOL, 10(11), 1999, pp. 1301-1305

Authors: Thomas, L Leyh, H Marberger, M Bombardieri, E Bassi, P Pagano, F Pansadoro, V Sternberg, CN Boccon-Gibod, L Ravery, V Le Guludec, D Meulemans, A Conort, P Ishak, L
Citation: L. Thomas et al., Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer, CLIN CHEM, 45(4), 1999, pp. 472-477

Authors: Sternberg, CN Calabro, F Marini, L Scavina, P
Citation: Cn. Sternberg et al., Systemic chemotherapy of muscle-invasive bladder cancer, OX MED PUBL, 1999, pp. 299-315

Authors: Sternberg, CN Lanari, A Newling, DWW
Citation: Cn. Sternberg et al., Chemotherapy in advanced prostate cancer, TEXTBOOK OF PROSTATE CANCER, 1999, pp. 319-329
Risultati: 1-16 |